Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 28,495,649
- Total 13F shares
- 66,115,361
- Share change
- -2,547,504
- Total reported value
- $48,286,884
- Price per share
- $0.73
- Number of holders
- 55
- Value change
- -$1,938,715
- Number of buys
- 14
- Number of sells
- 30
Quarterly Holders Quick Answers
What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 68235C107:
Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
|
Company |
82%
|
23,353,697
|
$21,011,000 | — | 30 Jun 2022 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
63%
|
18,056,274
|
$16,245,000 | — | 30 Jun 2022 | |
| AWM Investment Company, Inc. |
13F
|
Company |
27%
|
7,746,557
|
$6,970,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
15%
|
4,346,530
|
$3,911,000 | — | 30 Jun 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
10%
|
2,837,800
|
$2,553,000 | — | 30 Jun 2022 | |
| Defender Capital, LLC. |
13F
|
Company |
9.1%
|
2,589,380
|
$2,330,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.2%
|
2,343,426
|
$2,108,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.5%
|
996,169
|
$896,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.4%
|
973,322
|
$875,000 | — | 30 Jun 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
3.4%
|
957,400
|
$862,000 | — | 30 Jun 2022 | |
| Penbrook Management LLC |
13F
|
Company |
2%
|
575,750
|
$518,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.9%
|
541,983
|
$487,000 | — | 30 Jun 2022 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
330,000
|
$297,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
327,145
|
$294,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.88%
|
251,459
|
$226,000 | — | 30 Jun 2022 | |
| Ergoteles LLC |
13F
|
Company |
0.81%
|
232,133
|
$209,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
208,799
|
$188,000 | — | 30 Jun 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.72%
|
205,300
|
$185,000 | — | 30 Jun 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.56%
|
160,238
|
$144,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.52%
|
147,906
|
$134,000 | — | 30 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.51%
|
145,804
|
$131,000 | — | 30 Jun 2022 | |
| Fort Sheridan Advisors LLC |
13F
|
Company |
0.47%
|
135,000
|
$121,000 | — | 30 Jun 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.41%
|
117,596
|
$106,000 | — | 30 Jun 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0.11%
|
32,001
|
$106,000 | — | 30 Jun 2022 | |
| LPL Financial LLC |
13F
|
Company |
0.38%
|
108,816
|
$98,000 | — | 30 Jun 2022 | |
| Li Yu |
3/4/5
|
VP Cntrllr/Prncpl Acctng Offcr |
—
mixed-class rows
|
41,872
mixed-class rows
|
$76,536 | — | 18 May 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.29%
|
82,096
|
$74,000 | — | 30 Jun 2022 | |
| CALIBER WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
75,120
|
$68,000 | — | 30 Jun 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.24%
|
67,670
|
$61,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
63,254
|
$57,000 | — | 30 Jun 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
62,284
|
$57,000 | — | 30 Jun 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.21%
|
58,530
|
$53,000 | — | 30 Jun 2022 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
0.17%
|
49,000
|
$44,000 | — | 30 Jun 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.13%
|
36,600
|
$33,000 | — | 30 Jun 2022 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.13%
|
36,500
|
$33,000 | — | 30 Jun 2022 | |
| LMR Partners LLP |
13F
|
Company |
0.11%
|
31,463
|
$28,000 | — | 30 Jun 2022 | |
| Jump Financial, LLC |
13F
|
Company |
0.1%
|
29,140
|
$26,000 | — | 30 Jun 2022 | |
| Cavan M. Redmond |
3/4/5
|
Director |
—
class O/S missing
|
120,863
|
$25,973 | — | 24 Jun 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.1%
|
27,240
|
$25,000 | — | 30 Jun 2022 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.09%
|
26,996
|
$24,000 | — | 30 Jun 2022 | |
| DCF Advisers, LLC |
13F
|
Company |
0.09%
|
25,149
|
$23,000 | — | 30 Jun 2022 | |
| American Portfolios Advisors |
13F
|
Company |
0.08%
|
21,830
|
$19,640 | — | 30 Jun 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.07%
|
21,217
|
$19,000 | — | 30 Jun 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.07%
|
20,741
|
$19,000 | — | 30 Jun 2022 | |
| Mitchell S. Levine |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
174,580
mixed-class rows
|
$18,713 | — | 15 Mar 2022 | |
| Westshore Wealth, LLC |
13F
|
Company |
0.07%
|
20,000
|
$18,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
19,906
|
$18,000 | — | 30 Jun 2022 | |
| Cinctive Capital Management LP |
13F
|
Company |
0.07%
|
19,565
|
$18,000 | — | 30 Jun 2022 | |
| Creative Planning |
13F
|
Company |
0.07%
|
18,609
|
$17,000 | — | 30 Jun 2022 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.06%
|
17,139
|
$15,000 | — | 30 Jun 2022 |
Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q3 2022
As of 30 Sep 2022,
Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,115,361 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, PURA VIDA INVESTMENTS, LLC, AWM Investment Company, Inc., VANGUARD GROUP INC, Defender Capital, LLC., BlackRock Inc., ORBIMED ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Schonfeld Strategic Advisors LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
64
Q3 2022 holders
55
Holder diff
-9
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.